Evidence map›Paper›PMID 17399883›Full record

ReviewBiochimie

The IRF family, revisited.

A Paun, P M Pitha

Open access · greenAbstract readReview
In one paragraph

Review in Biochimie. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 132 papers.

0numbers the graph read from it
0cells of the map it votes in
132citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

132 citing papers in PubMed, 269 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. TLRs: Innate Immune Sentries against SARS-CoV-2 Infection.International journal of molecular sciences · 2023
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

72 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

A PaunDivision of Viral Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.
P M Pitha
Sidney Kimmel Comprehensive Cancer Center · US

Funding

VIRUS/IFN INDUCED SIGNALING PATHWAY IN PATHOGENICITYR01AI019737 · NIAID · JOHNS HOPKINS UNIVERSITY · PI PITHA-ROWE, PAULA M · 1985 to 2006
$1.6M
NIAID NIH HHS R01 AI019737NIAID NIH HHS R01 AI19737-19
6 · The paper itself

Abstract

Since the discovery of interferon 50 years ago a great deal of progress has been made in understanding how interferons work and how and why they are induced. Key factors in interferon induction are the interferon regulatory factors (IRF). In this review of IRF we aim to show you not only the historical side of the IRF but also the integral, anti-viral and hematopoetic roles of these transcription factors, as well as the sometimes surprising and even forgotten roles that these proteins play, not only in interferon signaling but throughout the immune system and the body as a whole. Further research will no doubt expand the repertoire of these multifunctional proteins even more.

Indexed as

AnimalsAntiviral AgentsHematopoiesisHumansImmune SystemInterferon Regulatory FactorsInterferonsModels, BiologicalRepressor ProteinsResponse ElementsSignal TransductionTranscription FactorsViral ProteinsAntiviral AgentsInterferon Regulatory FactorsInterferonsRepressor ProteinsTranscription FactorsViral Proteins

Identifiers

PMID17399883
PMCPMC2139905
OpenAlexW2000329335

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.